Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination.

Ferdinands JM, Shay DK.

Clin Infect Dis. 2012 Jan 1;54(1):25-32. doi: 10.1093/cid/cir750. Epub 2011 Nov 17.

PMID:
22095567
2.

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Osterholm MT, Kelley NS, Sommer A, Belongia EA.

Lancet Infect Dis. 2012 Jan;12(1):36-44. doi: 10.1016/S1473-3099(11)70295-X. Epub 2011 Oct 25. Review. Erratum in: Lancet Infect Dis. 2012 Sep;12(9):655.

PMID:
22032844
3.

Japanese universal health coverage: evolution, achievements, and challenges.

Ikegami N, Yoo BK, Hashimoto H, Matsumoto M, Ogata H, Babazono A, Watanabe R, Shibuya K, Yang BM, Reich MR, Kobayashi Y.

Lancet. 2011 Sep 17;378(9796):1106-15. doi: 10.1016/S0140-6736(11)60828-3. Epub 2011 Aug 30.

PMID:
21885107
4.

Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.

Mahmud S, Hammond G, Elliott L, Hilderman T, Kurbis C, Caetano P, Van Caeseele P, Kettner J, Dawood M.

Vaccine. 2011 Oct 19;29(45):7975-81. doi: 10.1016/j.vaccine.2011.08.068. Epub 2011 Aug 30.

PMID:
21884747
5.

Performance of rapid influenza H1N1 diagnostic tests: a meta-analysis.

Chu H, Lofgren ET, Halloran ME, Kuan PF, Hudgens M, Cole SR.

Influenza Other Respir Viruses. 2012 Mar;6(2):80-6. doi: 10.1111/j.1750-2659.2011.00284.x. Epub 2011 Aug 31.

6.

Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities.

Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, Ohmit SE, Coleman LA, Lofthus G, Petrie JG, Meece JK, Hall CB, Williams JV, Gargiullo P, Berman L, Shay DK; U.S. Flu-VE Network.

PLoS One. 2011;6(8):e23085. doi: 10.1371/journal.pone.0023085. Epub 2011 Aug 12.

7.

A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups.

Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S.

Vaccine. 2011 Nov 15;29(49):9159-70. doi: 10.1016/j.vaccine.2011.08.008. Epub 2011 Aug 12. Review.

PMID:
21840359
8.

Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study.

Cheng AC, Kotsimbos T, Kelly HA, Irving LB, Bowler SD, Brown SG, Holmes M, Jenkins CR, Thompson P, Simpson G, Wood-Baker R, Senanayake SN, Brady SJ, Paterson DL, Wark PA, Upham JW, Korman TM, Dwyer DE, Waterer GW, Kelly PM.

Vaccine. 2011 Oct 6;29(43):7320-5. doi: 10.1016/j.vaccine.2011.07.087. Epub 2011 Jul 31.

PMID:
21810450
9.

Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.

Steens A, Wijnans EG, Dieleman JP, Sturkenboom MC, van der Sande MA, van der Hoek W.

BMC Infect Dis. 2011 Jul 18;11:196. doi: 10.1186/1471-2334-11-196.

10.

Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010.

Fielding JE, Grant KA, Garcia K, Kelly HA.

Emerg Infect Dis. 2011 Jul;17(7):1181-7. doi: 10.3201/eid1707.101959.

11.

Effects of vaccination against pandemic (H1N1) 2009 among Japanese children.

Nishiura H, Oshitani H.

Emerg Infect Dis. 2011 Apr;17(4):746-7. doi: 10.3201/eid1706.100525. No abstract available.

12.

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.

Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, Nunes B, Pitigoi D, Larrauri Cámara A, Mosnier A, Horvath JK, O'Donnell J, Bella A, Guiomar R, Lupulescu E, Savulescu C, Ciancio BC, Kramarz P, Moren A.

PLoS Med. 2011 Jan;8(1):e1000388. doi: 10.1371/journal.pmed.1000388. Epub 2011 Jan 11.

13.

Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures.

Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS.

J Infect Dis. 2011 May 1;203(9):1309-15. doi: 10.1093/infdis/jir015. Epub 2011 Mar 4.

14.

Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis.

Castilla J, Moran J, Martinez-Artola V, Reina G, Martinez-Baz I, Garcia Cenoz M, Alvarez N, Irisarri F, Arriazu M, Elia F, Salcedo E.

Euro Surveill. 2011 Feb 17;16(7). pii: 19799.

15.

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.

Ambrose CS, Levin MJ, Belshe RB.

Influenza Other Respir Viruses. 2011 Mar;5(2):67-75. doi: 10.1111/j.1750-2659.2010.00183.x. Epub 2010 Nov 19. Review.

16.

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.

Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, Kwindt TL, Tang P, Charest H, Fonseca K, Gubbay JB, Bastien N, Li Y, Petric M.

BMJ. 2011 Feb 3;342:c7297. doi: 10.1136/bmj.c7297.

17.

The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons.

Katayose M, Hosoya M, Haneda T, Yamaguchi H, Kawasaki Y, Sato M, Wright PF.

Vaccine. 2011 Feb 17;29(9):1844-9. doi: 10.1016/j.vaccine.2010.12.049. Epub 2010 Dec 31.

PMID:
21195802
18.

Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks.

Valenciano M, Kissling E, Ciancio BC, Moren A.

Vaccine. 2010 Oct 28;28(46):7381-8. doi: 10.1016/j.vaccine.2010.09.010. Epub 2010 Sep 17.

PMID:
20851086
19.

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62. Erratum in: MMWR Recomm Rep. 2010 Aug 13;59(31):993. MMWR Recomm Rep. 2010 Sep 10;59(35):1147.

20.

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.

Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG.

N Engl J Med. 2010 May 6;362(18):1708-19. doi: 10.1056/NEJMra1000449. Review. No abstract available. Erratum in: N Engl J Med. 2010 May 27;362(21):2039.

Supplemental Content

Support Center